Steven Jungerwirth

585 total citations
8 papers, 483 citations indexed

About

Steven Jungerwirth is a scholar working on Rheumatology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Steven Jungerwirth has authored 8 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Steven Jungerwirth's work include Rheumatoid Arthritis Research and Therapies (5 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Steven Jungerwirth is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Steven Jungerwirth collaborates with scholars based in United States, Austria and Canada. Steven Jungerwirth's co-authors include Heidi S. Camp, Ahmed A. Othman, Aileen L. Pangan, Li Wang, Nasser Khan, Michael E. Weinblatt, Joel M. Kremer, Paul Emery, Josef S Smolen and Sebastian Meerwein and has published in prestigious journals such as Annals of Surgery, Annals of the Rheumatic Diseases and Thorax.

In The Last Decade

Steven Jungerwirth

8 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Jungerwirth United States 7 264 158 134 92 72 8 483
Isabelle Madelaine‐Chambrin France 12 85 0.3× 387 2.4× 91 0.7× 45 0.5× 51 0.7× 20 717
Masayuki Miyata Japan 14 172 0.7× 47 0.3× 74 0.6× 85 0.9× 51 0.7× 43 547
David L. Hyslop United States 7 196 0.7× 81 0.5× 89 0.7× 54 0.6× 63 0.9× 14 394
Eva Salgado Spain 12 506 1.9× 67 0.4× 141 1.1× 260 2.8× 104 1.4× 22 804
J.M. Kremer United States 10 551 2.1× 54 0.3× 269 2.0× 194 2.1× 169 2.3× 27 798
Ani John United States 14 416 1.6× 46 0.3× 166 1.2× 107 1.2× 103 1.4× 30 575
Nicole L Byers United States 5 167 0.6× 91 0.6× 75 0.6× 90 1.0× 53 0.7× 5 377
Hideko Kozuru Japan 11 98 0.4× 53 0.3× 38 0.3× 130 1.4× 19 0.3× 12 351
Kumi Shidara Japan 16 430 1.6× 32 0.2× 126 0.9× 86 0.9× 99 1.4× 30 586
M Bouvier United States 11 34 0.1× 175 1.1× 427 3.2× 143 1.6× 67 0.9× 29 688

Countries citing papers authored by Steven Jungerwirth

Since Specialization
Citations

This map shows the geographic impact of Steven Jungerwirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Jungerwirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Jungerwirth more than expected).

Fields of papers citing papers by Steven Jungerwirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Jungerwirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Jungerwirth. The network helps show where Steven Jungerwirth may publish in the future.

Co-authorship network of co-authors of Steven Jungerwirth

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Jungerwirth. A scholar is included among the top collaborators of Steven Jungerwirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Jungerwirth. Steven Jungerwirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mohamed, Mohamed‐Eslam F., Steven Jungerwirth, Armen Asatryan, Ping Jiang, & Mohamed I. A. Othman. (2017). Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high‐fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib. British Journal of Clinical Pharmacology. 83(10). 2242–2248. 53 indexed citations
2.
Kremer, Joel M., Ed Keystone, Paul Emery, et al.. (2016). AB0390 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance To Anti-TNF Biologic Therapy. Annals of the Rheumatic Diseases. 75. 1038–1039. 7 indexed citations
3.
Genovese, Mark C., Josef S Smolen, Michael E. Weinblatt, et al.. (2016). OP0223 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis with An Inadequate Response To Methotrexate. Annals of the Rheumatic Diseases. 75. 141–142. 1 indexed citations
4.
Genovese, Mark C., Josef S Smolen, Michael E. Weinblatt, et al.. (2016). Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Arthritis & Rheumatology. 68(12). 2857–2866. 170 indexed citations
5.
Kremer, Joel M., Paul Emery, Heidi S. Camp, et al.. (2016). A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy. Arthritis & Rheumatology. 68(12). 2867–2877. 148 indexed citations
6.
Cohn, Stephen M., Pamela A. Lipsett, Timothy G. Buchman, et al.. (2000). Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections. Annals of Surgery. 232(2). 254–262. 76 indexed citations
7.
Byyny, Richard L., et al.. (1997). Efficacy and Safety of Nifedipine Coat-Core versus Amlodipine in Patients With Mild to Moderate Essential Hypertension: Comparison of 24-Hour Mean Ambulatory Diastolic Blood Pressure. Journal of Cardiovascular Pharmacology and Therapeutics. 2(2). 77–83. 9 indexed citations
8.
Fischer, Andrew R., et al.. (1997). Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax. 52(12). 1074–1077. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Madelaine‐Chambrin Breakdown of academic impact, for papers by Masayuki Miyata Breakdown of academic impact, for papers by David L. Hyslop Breakdown of academic impact, for papers by Eva Salgado Breakdown of academic impact, for papers by J.M. Kremer Breakdown of academic impact, for papers by Ani John Breakdown of academic impact, for papers by Nicole L Byers Breakdown of academic impact, for papers by Hideko Kozuru Breakdown of academic impact, for papers by Kumi Shidara Breakdown of academic impact, for papers by M Bouvier
Rankless by CCL
2026